Pressemitteilungen

ERC grant for Stefan Pfister: “We must further advance pediatric cancer research”

 

KiTZ director Stefan Pfister, professor of pediatric neurooncology at the German Cancer Research Center (DKFZ) and the Heidelberg University Hospital,...

COMPASS: The guide to new therapies for children with cancer

 

By a targeted combination of molecular and microscopy-based techniques, researchers aim to identify new treatment approaches for children with cancer....

The sleeping beauty among brain tumor cells

 

Scientists from the Hopp Children's Tumor Center Heidelberg (KiTZ), together with two other teams from the German Cancer Association (DKTK) and...

Mayer Foundation provides €1.5 million for research on Ewing sarcoma in children

 

In a new research consortium, scientists from the "Hopp Children's Cancer Center Heidelberg" (KiTZ), together with working groups from Ludwig...

Taking a look at the genes of brain tumors may help making the right therapy decision

 

Researchers from the „Hopp-Children’s Cancer Center Heidelberg“ (KiTZ) together with colleagues from the US, showed substantial molecular diversity...

KiTZ Junior Group Leader receives ERC grant

 

The European Research Council (ERC) awards Starting Grants to support excellent young scientists when they are starting an independent science career....

Epigenetic analysis: Giving the right name to a tumor

 

Scientists from the “Hopp Children's Cancer Center at the NCT Heidelberg” (KiTZ) and the Neuropathology Department at Heidelberg University Hospital...

A molecular map of childhood cancers

 

Researchers led by Professor Stefan Pfister from the “Hopp Children's Cancer Center at the NCT Heidelberg” (KiTZ) have been able to draw an extremely...

Kristian Pajtler received $100,000 award for brain cancer research

 

Kristian Pajtler, a pediatric oncologist from the “Hopp Children’s Cancer Center at the NCT Heidelberg” (KiTZ), received the 2018 CERN Scientific...

Molekular Super Enhancers: Molecular super enhancers: A new key for targeted therapy of brain cancer in children

 

Ependymoma refers to a heterogeneous group of cancers that can occur at any age and is one of the most common types of brain cancer in children. The...